Orgeval, France

Denis Gicquel

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Denis Gicquel

Introduction

Denis Gicquel, an accomplished inventor located in Orgeval, France, has made significant contributions to the pharmaceutical field. With a total of three patents to his name, Denis specializes in the development of innovative solutions that enhance therapeutic options for patients. His latest inventions focus on the formulation of pharmaceutical tablets, showcasing his dedication to advancing medical treatments.

Latest Patents

Denis Gicquel’s most notable recent patent involves ulipristal acetate tablets. This invention relates to a pharmaceutical tablet designed for oral administration that comprises ulipristal acetate alongside various excipients. The formulation includes at least one diluent in an amount of 50 to 98.5 wt %, a binding agent in an amount of 0 to 10 wt %, a disintegrating agent in an amount of 0.5 to 10 wt %, and a lubricant in an amount of 0 to 10 wt %. This innovative formulation holds great potential for improving patient outcomes.

Career Highlights

Denis works at Laboratoire HRA-Pharma, where he applies his expertise in pharmaceutical sciences to create effective medication solutions. His role allows him to leverage his inventive capabilities and contribute to numerous projects that aim to meet unaddressed medical needs.

Collaborations

In his professional journey, Denis has had the pleasure of collaborating with talented coworkers such as Erin Gainer and Helene Guillard. These partnerships foster a creative environment that enhances the development of innovative products, ultimately benefiting the healthcare industry.

Conclusion

Denis Gicquel exemplifies the spirit of innovation within the pharmaceutical sector. With a growing portfolio of patents, he continues to make strides in drug formulation, ensuring that patients have access to effective medication options. His collaborations and work at Laboratoire HRA-Pharma position him as a key player in advancing pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…